Clinical Trial Update: Genomic Imprinting Testing for Diagnosis of Bladder Cancer

View source ↗

Summary

This clinical trial update discusses genomic imprinting testing as a potential diagnostic for bladder cancer, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Changhai Hospital | Conditions: Bladder Cancer, Urine Marking | Status: UNKNOWN